The 29 portfolio companies we’ve helped build have attracted more than $2.3B of risk capital, employ close to 1,000 Canadians and have a combined value of $4B.
Nexelis is an immunology-centric CRO specialized in preclinical models and clinical assay development in single and multiplex formats and sample analysis for low-, mid- and large-scale clinical testing.